Home Categories API Tranilast
A7820212

Tranilast , ≥98%(HPLC) , 53902-12-8

Synonym(s):
3,4-DAA;N-(3?,4?-Dimethoxycinnamoyl)anthranilic Acid;N-(3,4-Dimethoxycinnamoyl)anthranilic acid;Rizaben;2-[[3-(3,4-Dimethoxyphenyl)-1-oxo-2-propenyl]amino] benzoic acid

CAS NO.:53902-12-8

Empirical Formula: C18H17NO5

Molecular Weight: 327.33

MDL number: MFCD00864787

Pack Size Price Stock Quantity
250mg RMB28.00 In Stock
1G RMB45.60 In Stock
5G RMB134.40 In Stock
25g RMB571.20 In Stock
100g RMB2063.20 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: 166.2-168.2 °C (lit.)
Boiling point: 465.23°C (rough estimate)
Density  1.3185 (rough estimate)
refractive index  1.5100 (estimate)
storage temp.  2-8°C
solubility  DMSO: 18 mg/mL
form  powder
pka 3.47±0.36(Predicted)
color  white to beige
Merck  14,9570
Stability: Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 3 months.
InChI 1S/C18H17NO5/c1-23-15-9-7-12(11-16(15)24-2)8-10-17(20)19-14-6-4-3-5-13(14)18(21)22/h3-11H,1-2H3,(H,19,20)(H,21,22)/b10-8+
InChIKey NZHGWWWHIYHZNX-CSKARUKUSA-N
SMILES COc1ccc(\C=C\C(=O)Nc2ccccc2C(O)=O)cc1OC
CAS DataBase Reference 53902-12-8(CAS DataBase Reference)

Description and Uses

Tranilast (53902-12-8) is an anti-allergy agent (inhibitor of mast cell degranulation) that has been shown to have potent immunomodulatory effects via inhibition of endotoxin induced: PGE2, IC50 = 1-20 μM; TXB2, IC50 = 10-50 μM; TGFβ1, IC50 = 100-200 μM; IL-8, IC50 = 100 μM .1-3 Tranilast also displays anti-angiogenic properties.4,5

coronary vasodilator

Safety

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H302
Precautionary statements  P264-P270-P301+P312-P501
PPE dust mask type N95 (US), Eyeshields, Gloves
Hazard Codes  Xn
Risk Statements  22
Safety Statements  26-36
WGK Germany  3
RTECS  DG8731000
HS Code  2924.29.6250
Storage Class 11 - Combustible Solids
Hazard Classifications Acute Tox. 4 Oral
Toxicity LD50 in male, female mice, male, female rats (mg/kg): 780, 680, 1600, 1100 orally; 410, 385, 405, 395 i.p.; 2630, 2820, 3630, 3060 s.c. (Nakazawa, p 385)

RELATED PRODUCTS